161 results for "Singer, Eric A."
Showing 1–20 · 1.62 seconds · RSS
-
Journal Article Full text
Intravenous Therapies for Castration-Resistant Prostate Cancer: Toxicities and Adverse Events
Prostate cancer continues to be a significant burden on men's health. While significant advances have been made in the diagnosis and treatment of localized disease, androgen deprivation therapy remains the therapy of choice for advanced and metastatic disease. However, once a man progresses on…
-
Journal Article Full text
Our Shifting Understanding of Factors Influencing Prostate-Specific Antigen
-
Journal Article Full text
Perioperative Advance Directives: Do Not Resuscitate in the Operating Room
-
Journal Article Full text
Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis
Papillary renal cell carcinoma (pRCC) is a heterogeneous and incompletely understood histologic subtype of kidney cancer. Recently, authors from The Cancer Genome Atlas Research Network performed a comprehensive molecular characterization of pRCC. Using multiple analytic methods, they identified 4…
-
Journal Article Full text
Immuno-oncologic care during COVID-19: Challenges and opportunities for improving clinical care and investigation
Cancer care has been greatly impacted during the COVID-19 pandemic. The number of cases and deaths caused by the COVID-19 pandemic continues to escalate throughout the United States and the world. Worldwide, over 150 million people have been diagnosed with the coronavirus and more than 3 million…
-
Journal Article Full text
Cancer Care Economics of Bladder Cancer: Cost-Enhancing Factors and Possible Cost Reduction
PURPOSE OF REVIEW: The diagnosis and care of bladder cancer (BC) represents a significant financial burden to the population in the United States. Therapeutic advances in BC care have come at a high cost to payers, providers, and patients. This study describes the principals of economic evaluation…
-
Journal Article Full text
Update on Targeted Therapies for Clear Cell Renal Cell Carcinoma
VEGF and mTOR-targeted therapies continue to play a critical role in the management of advanced and metastatic RCC. Ongoing research to identify novel agents continues to build upon the work done during the elucidation of the VHL/clear cell RCC pathway. It is hoped that ongoing and planned studies…
-
Journal Article Full text
Targeted Therapeutic Strategies for the Management of Renal Cell Carcinoma
Agents targeting the VEGF and mTOR pathways remain the mainstay in the management of metastatic RCC. Understanding the importance of the VHL/HIF pathway in clear cell RCC has hitherto guided targeted therapy options in this disease, but other potential targets are beginning to emerge. Ongoing and…
-
Journal Article Full text
Implications of the Revised Common Rule for Human Participant Research
This paper looks at the implications of changes to the regulatory governance of human participant research that can be expected with implementation of the Revised Common Rule (RCR). The RCR refers to revisions of the existing federal regulations that govern the performance of research involving…
-
Journal Article Full text
Renal Cell Carcinoma: Molecular Characterization and Evolving Treatment Paradigms
PURPOSE OF REVIEW: The treatment landscape of advanced renal cell carcinoma (RCC) continues to shift as both new targeted therapies and immunotherapies show efficacy in treating the disease. Contemporary insights into the molecular characterization of RCC are likely to fuel the development of…
-
Journal Article Full text
To Be or “Node” to Be: Nodal Disease and the Role of Lymphadenectomy in the Treatment of Renal Cell Carcinoma
Lymph node involvement in renal cell carcinoma (RCC) correlates with poor oncologic outcomes. However, current RCC staging guidelines may not fully reflect the survival impact of lymph node positive disease. Recent data demonstrates that nodal disease has significant impact on survival and…
-
Journal Article Full text
Special issues raised by evolving areas of clinical research
Each study presents its own set of ethical considerations. Certain kinds of ethical issues are inherent in particular areas of clinical research, regardless of specific ethical questions associated with a specific study. In this chapter, some of the most common special areas of clinical research…
-
Journal Article Full text
Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma
The recent FDA approval of multiple new pharmaceutical agents for metastatic renal cell carcinoma (RCC) has left physicians with several options for first- and second- line therapy. With limited head-to-head comparisons, however, there is a paucity of evidence to recommend the use of one agent over…
-
Journal Article Full text
Futility and the Care of Surgical Patients: Ethical Dilemmas
Futility has been a contentious topic in medicine for several decades. Surgery in critical or end-of-life situations often raises difficult questions about futility. In this article, we discuss the definition of futility, methods for resolving futility disputes, and some ways to reframe the…